Inflammatory bowel disease

Original
Year 2024 / Volume 116 / Number 4
193-200
DOI: 10.17235/reed.2023.9935/2023
Lorena Jara Fernández, Juan Ángel Ferrer, José Lázaro Pérez Calle, Laura Martínez Álvarez, Pilar López Serrano,
Background and objectives: inflammatory bowel disease (IBD) has a major impact on psychological well-being. This condition is associated with a high level of anxiety and mood disorders, but stress prevalence...
Reader rating:
Share Button
Letter
Year 2024 / Volume 116 / Number 4
233-234
DOI: 10.17235/reed.2023.9950/2023
Youyan Jin, Wei Wei, Cong Hou, Zehong Liang, Jiali Wang, Huang Zhong,
Current treatments for patients in the active phase of Crohn's disease (CD) include conventional treatments and biological treatments. Infliximab (IFX), a TNF-α antagonist, is recommended to induce remission...
Reader rating:
Share Button
Original
Year 2024 / Volume 116 / Number 3
124-131
DOI: 10.17235/reed.2023.9703/2023
Cong Dai, Zi-Yuan Dong, Yi-Nuo Wang, Yu-Hong Huang, Min Jiang,
Background: there are some patients with ulcerative colitis (UC) who have non-response (NR) to 5-aminosalicylic acid (5-ASA). To promote individualized treatment in UC patients, it is crucial to identify...
Reader rating:
Share Button
Letter
Year 2024 / Volume 116 / Number 3
176-177
DOI: 10.17235/reed.2023.9745/2023
Cong Dai, Yu-Hong Huang,
Ulcerative colitis (UC) is a chronic inflammatory disorder of the gastrointestinal tract. Tumor necrosis factor (TNF) inhibitors such as infliximab (IFX) are used to treat UC. But TNF inhibitors can induce...
Reader rating:
Share Button
Letter
Year 2024 / Volume 116 / Number 3
175-176
DOI: 10.17235/reed.2023.9472/2023
Laura Gutiérrez-Rios, Eva Vayreda, Margalida Calafat, Míriam Mañosa, Eugeni Domènech, Fiorella Cañete,
A 48-year-old man with a diagnosis of ulcerative colitis 18 years ago, under immunosuppressive treatment with azathioprine in the last 6 years due to corticosteroid dependence, was admitted to the Emergency...
Reader rating:
Share Button
Letter
Year 2024 / Volume 116 / Number 3
165-166
DOI: 10.17235/reed.2023.9623/2023
Jiaoting Chen, Ning Su, Yan Huang, Min Zhang, Jiayin Yao, Guolin Li, Tenghui Ma, Min Zhi,
Indolent T-cell lymphoma is a rare disease. Here we presented a 53-year-old male patient initially diagnosed as ulcerative colitis in 2000 that finally developed into extensive indolent T-cell lymphoma...
Reader rating:
Share Button
Original
Year 2024 / Volume 116 / Number 2
77-82
DOI: 10.17235/reed.2023.9754/2023
Shengduo He, Hong Jiang, Yu Tian, Wei Zhang, Guigen Teng, Huahong Wang,
Background: ulcerative colitis (UC) overall disease severity index (DSI) has been established. A prospective cohort study was performed to find the value of DSI to predict colectomy within one and four...
Reader rating:
Share Button
Original
Year 2024 / Volume 116 / Number 2
68-76
DOI: 10.17235/reed.2023.9808/2023
Yue Feng, Weihua Feng, Mei Xu, Chaoping Wu, Huanhuan Yang, Yu Wang, Huatian Gan,
Background: The association between sarcopenia and treatment outcomes in inflammatory bowel disease (IBD) is currently a subject of controversy. Methods: A systematic search was performed of PubMed,...
Reader rating:
Share Button
Letter
Year 2024 / Volume 116 / Number 1
49-51
DOI: 10.17235/reed.2023.9599/2023
Jorge Barajas Pérez, Óscar Moralejo Lozano, Natalia María Arietti López, Laura Monserrat López Torres, Raquel Olvido Lomas Pérez, Concepción Muñoz Rosas, Rafael Ángel Gómez Rodríguez,
Rectal perforations due to topical treatments (enemas or foams) are unusual complications and they have been mostly reported in the use of barium enemas or in elderly patients with constipation. Very little...
Reader rating:
Share Button
Original
Year 2023 / Volume 115 / Number 12
686-692
DOI: 10.17235/reed.2023.9402/2022
Raúl Vicente Olmedo Martín, Juan María Vázquez Morón, María del Mar Martín Rodríguez, Marta Lázaro Sáez, Álvaro Hernández Martínez, Federico Argüelles-Arias,
Background: ustekinumab has proven effective in Crohn’s disease (CD). However, some patients will partially respond or lose response over time. Data supporting the effectiveness of dose escalation in this...
Reader rating:
Share Button

Page 1 of 15
1
2
3
4
5
6
7
>>
Submission and tracking of manuscripts
Instructions to authors

Submission and tracking

Asociación Española de Ecografía Digestiva Sociedad Española de Endoscopia Digestiva Sociedad Española de Patología Digestiva
The Spanish Journal of Gastroenterology is the official organ of the Sociedad Española de Patología Digestiva, the Sociedad Española de Endoscopia Digestiva and the Asociación Española de Ecografía Digestiva
Cookie policy Privacy Policy Legal Notice © Copyright 2023 y Creative Commons. The Spanish Journal of Gastroenterology